Multi-drug-resistant tuberculosis epidemiology and demographics: Difference between revisions
| Line 16: | Line 16: | ||
*The frequency of MDR TB varies substantially among countries. | *The frequency of MDR TB varies substantially among countries. | ||
*10 % of MDR- TB cases are also resistant to two second line drug classes or XDR (Extensively drug resistant TB) | *10 % of MDR- TB cases are also resistant to two second line drug classes or XDR (Extensively drug resistant TB) | ||
*92 countries have reported | *92 countries have reported at least oe XDR case by September 2013. | ||
*About 450 000 people developed MDR-TB in the world in 2012. More than half of these cases were in India, China and the Russian Federation. | *About 450 000 people developed MDR-TB in the world in 2012. More than half of these cases were in India, China and the Russian Federation. | ||
*It is estimated that about 9.6% of MDR-TB cases had XDR-TB. | *It is estimated that about 9.6% of MDR-TB cases had XDR-TB. | ||
[[File:Notified MDR-TB cases (absolute numbers), 2012.png|thumb|center|500px|Notified MDR-TB cases (absolute numbers), 2012.png <SMALL><SMALL> ''[https://extranet.who.int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G2/PROD/EXT/MDRTB_Indicators_map)]''<ref name="WHO">{{Cite web | title = World health organization (WHO) | url = https://extranet.who.int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G2/PROD/EXT/MDRTB_Indicators_map}}</ref></SMALL></SMALL>]] | [[File:Notified MDR-TB cases (absolute numbers), 2012.png|thumb|center|500px|Notified MDR-TB cases (absolute numbers), 2012.png <SMALL><SMALL> ''[https://extranet.who.int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G2/PROD/EXT/MDRTB_Indicators_map)]''<ref name="WHO">{{Cite web | title = World health organization (WHO) | url = https://extranet.who.int/sree/Reports?op=vs&path=/WHO_HQ_Reports/G2/PROD/EXT/MDRTB_Indicators_map}}</ref></SMALL></SMALL>]] | ||
<div style= "float:left;"> | |||
{| | |||
|[[File:Primary MDR TB, United States, 1993–2013 .png|thumb|500px|Primary MDR TB, United States, 1993–2013 <ref name="CDC">{{Cite web | title = Center for Disease Control and Prevention (CDC) | url = http://www.cdc.gov/tb/statistics/surv/surv2013/slides/surv22.htm}}</ref>]] | |[[File:Primary MDR TB, United States, 1993–2013 .png|thumb|500px|Primary MDR TB, United States, 1993–2013 <ref name="CDC">{{Cite web | title = Center for Disease Control and Prevention (CDC) | url = http://www.cdc.gov/tb/statistics/surv/surv2013/slides/surv22.htm}}</ref>]] | ||
|[[File:Primary Anti-TB Drug Resistance, United States, 1993–2013 .png|thumb|center|500 px|Primary Anti-TB Drug Resistance <SMALL><SMALL>''[http://www.cdc.gov - Center for Disease Control and Prevention(CDC)]''<ref name="CDC">{{Cite web | title = Center for Disease Control and Prevention (CDC) | url = http://www.cdc.gov}}</ref></SMALL></SMALL>]] | |[[File:Primary Anti-TB Drug Resistance, United States, 1993–2013 .png|thumb|center|500 px|Primary Anti-TB Drug Resistance <SMALL><SMALL>''[http://www.cdc.gov - Center for Disease Control and Prevention(CDC)]''<ref name="CDC">{{Cite web | title = Center for Disease Control and Prevention (CDC) | url = http://www.cdc.gov}}</ref></SMALL></SMALL>]] | ||
| Line 30: | Line 30: | ||
|- | |- | ||
|[[File:Number and Percent of Unique and County-GENType Clustered Cases, United States, 2011–2013.png|thumb|500px|Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993–2013<SMALL><SMALL>''[http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5005a1.htm/ Adapted from Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5005a1.htm/}}</ref></SMALL></SMALL>]] | |[[File:Number and Percent of Unique and County-GENType Clustered Cases, United States, 2011–2013.png|thumb|500px|Primary Isoniazid Resistance in U.S.-born vs. Foreign-born Persons, United States, 1993–2013<SMALL><SMALL>''[http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5005a1.htm/ Adapted from Centers for Disease Control and Prevention.]''<ref name="PHIL">{{Cite web | title = Public Health Image Library (PHIL), Centers for Disease Control and Prevention | url = http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5005a1.htm/}}</ref></SMALL></SMALL>]] | ||
|} | |}</div> | ||
===Race=== | ===Race=== | ||
| Line 37: | Line 37: | ||
===Tuberculosis in prison=== | ===Tuberculosis in prison=== | ||
A rise in multi drug resistant strains of tuberculosis infection is found in prisons of developing countries as well as spanish prison and outbreaks in some prisons in New york city. <ref name=Strategies against multidrug-resistant tuberculosis>{{cite web | title = Strategies against multidrug-resistant tuberculosis| url =http://erj.ersjournals.com/content/20/36_suppl/66s.full}}</ref> | A rise in multi drug resistant strains of tuberculosis infection is found in prisons of developing countries as well as spanish prison and outbreaks in some prisons in New york city. <ref name=Strategies against multidrug-resistant tuberculosis>{{cite web | title = Strategies against multidrug-resistant tuberculosis| url =http://erj.ersjournals.com/content/20/36_suppl/66s.full}}</ref> | ||
==References== | ==References== | ||
Revision as of 20:19, 30 September 2014
|
Multi-drug-resistant tuberculosis Microchapters |
|
Differentiating Multi-drug-resistant tuberculosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multi-drug-resistant tuberculosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis epidemiology and demographics |
|
FDA on Multi-drug-resistant tuberculosis epidemiology and demographics |
|
CDC on Multi-drug-resistant tuberculosis epidemiology and demographics |
|
Multi-drug-resistant tuberculosis epidemiology and demographics in the news |
|
Blogs on Multi-drug-resistant tuberculosis epidemiology and demographics |
|
Directions to Hospitals Treating Multi-drug-resistant tuberculosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
Multi drug resistant tuberculosis has been emerging as an alarming threat due to the drug resistance developed due to inadequate treatment as well as slow gradual genetic mutations. People who are immunosupressed with diseases like HIV has a high chance of developing infection with multi drug resistant tuberculosis. The incidence of MDR varies substantially among countries. Prisons have a high incidence of multi drug resistant tuberculosis as well as people from soviet union have a high incidence of MDR TB
Epidemiology and Demographics
A 1997 survey of 35 countries found rates above 2% in about a third of the countries surveyed. The highest rates were in the former USSR, the Baltic states, Argentina, India and China, and was associated with poor or failing national Tuberculosis Control programmes. Likewise, the appearance of high rates of MDR-TB in New York city in the early 1990s was associated with the dismantling of public health programmes by the Reagan administration.[1][2]
MDR-TB can develop in the course of the treatment of fully sensitive TB and this is always the result of patients missing doses or failing to complete a course of treatment.
Thankfully, MDR-TB strains appear to be less fit and less transmissible. It has been known for many years that INH-resistant TB is less virulent in guinea pigs, and the epidemiological evidence is that MDR strains of TB do not dominate naturally. A study in Los Angeles found that only 6% of cases of MDR-TB were clustered. This should not be a cause for complacency: it must be remembered that MDR-TB has a mortality rate comparable to lung cancer. It must also be remembered that people who have weakened immune systems (because of diseases such as HIV or because of drugs) are more susceptible to catching TB.
Incidence
- 3.6 % of the new tubercular cases have multi drug resistant strains.
- About 20% of the previously treated strains have drug resistance.
- The frequency of MDR TB varies substantially among countries.
- 10 % of MDR- TB cases are also resistant to two second line drug classes or XDR (Extensively drug resistant TB)
- 92 countries have reported at least oe XDR case by September 2013.
- About 450 000 people developed MDR-TB in the world in 2012. More than half of these cases were in India, China and the Russian Federation.
- It is estimated that about 9.6% of MDR-TB cases had XDR-TB.
,_2012.png)
 |
 |
 |
 |
 |
Race
The highest amount of MDR-TB and resistance in United States is found in foreign born population especially from Soviet Union with 8.5 % and 33.5% of any resistance of TB in 2000.
Tuberculosis in prison
A rise in multi drug resistant strains of tuberculosis infection is found in prisons of developing countries as well as spanish prison and outbreaks in some prisons in New york city.
References
- ↑ Frieden TR, Sterling T, Pablos-Mendez A; et al. (1993). "The emergence of drug-resistant tuberculosis in New York City". N Engl J Med. 328 (8): 521&ndash, 56. PMID 8381207.
- ↑ Laurie Garrett (2000). Betrayal of trust: the collapse of global public health. New York: Hyperion. pp. 268ff. ISBN 0786884407 Check
|isbn=value: checksum (help). - ↑ "World health organization (WHO)".
- ↑ 4.0 4.1 "Center for Disease Control and Prevention (CDC)".
- ↑ 5.0 5.1 5.2 "Public Health Image Library (PHIL), Centers for Disease Control and Prevention".